Idiopathic intracranial hypertension · Papilledema · Ventriculoperitoneal shunt Abstract Purpose: To report a rare case of idiopathic intracranial hypertension (IIH) in a prepubertal pediatric patient. Case Report: The patient was an 11-year-old Japanese boy. Initially, an ophthalmologist found severe papilledema, and the patient was diagnosed with IIH. He was unresponsive to conservative therapy, and a ventriculoperitoneal shunt was inserted in the Neurosurgery Department because the visual impairment was severe. Twelve months after the shunt, the improvement in vision was limited due to optic disc atrophy. Conclusion: Ophthalmologists need to be more aware of II, especially in cases with severe papilledema that can lead to permanent reduction of vision.
Introduction
Idiopathic intracranial hypertension (IIH) is characterized by increased intracranial pressure in the absence of an intracranial space-occupying lesion, cerebral ventricular enlargement, or abnormal increase in the cerebrospinal fluid. In general, IIH affects obese women but can occasionally occur in children. The clinical features of children with IIH are different from those of adults [1] . There are also regional differences in the prevalence of IIH; in Japan, IIH affects only 0.03 individuals per 100,000 when adults and children are included [2] . We report our findings in an 11-year-old Japanese boy with IIH complicated by severe papilledema.
The patient was an 11-year-old boy with no notable medical or family history. For about 3 months, he had occasional general malaise, headaches, and vomiting. The patient then began to complain of difficulty in turning his neck and was referred to an orthopedic clinic. No abnormalities were detected in the head and neck in the computed tomographic (CT) images and the magnetic resonance images (MRIs). In addition, all hematological tests were within the normal limits.
After 1 month, the patient had a transient reduction in vision, and when his vision worsened in both eyes, the patient was brought to an ophthalmologist. At the initial examination, his visual acuity was 20/200 in the right eye and 20/100 in the left eye. The intraocular pressure of the right and left eyes was 19 and 20 mm Hg, respectively. No clear differences in the pupillary light reflexes of the right and left eyes were found. A relative afferent pupillary defect was not present. The anterior segment of the eye was normal, but ophthalmoscopy showed a marked swelling of the optic disc and severe retinal exudates in both eyes ( fig. 1 ).
The patient was admitted for comprehensive examinations on the same day. Physical and hematological abnormalities were not found. Head X-rays showed dehiscence of the coronal suture, which suggested intracranial hypertension. MRI showed no space-occupying lesions in the brain, but did show tortuous optic nerves, enlarged spinal fluid cavity, and flattened posterior sclera ( fig. 2 ). MR venography did not show clear signs of a sinus thrombosis. Cerebrospinal tap demonstrated a marked increase in the cerebrospinal pressure with an opening pressure of 350-500 mm H2O, but the cerebrospinal fluid contents were normal.
Based on these findings, the patient was diagnosed with IHH, and acetazolamide, concentrated glycerin, and steroid were injected intravenously. Initially, the intracranial pressure decreased after the treatment, but after 1 month, the intracranial hypertension and symptoms did not improved. Thus, a ventriculoperitoneal (VP) shunt was inserted in the Neurosurgery Department, and the intracranial pressure was lowered. The ophthalmological findings have been stable thereafter.
The changes in the fundus and visual field during the course of the disease process are shown in fig. 3 . At present, about 1 year after the onset, the papilledema has improved but the vision is 20/320 in the right eye and 20/2,000 in the left eye. The limited improvement of vision was most likely due to the optic nerve atrophy.
Discussion
In 1893, Quinke [3] reported a disease characterized by increased intracranial pressure in the absence of a space-occupying lesion in the brain, ventricular enlargement, and abnormalities of the cerebrospinal fluid. This disease was referred to as pseudotumor cerebri or benign intracranial hypertension. However, because it was determined that this disease can cause severe and permanent reduction of vision, the word 'benign' was deleted. Subsequently, it has been referred to as IIH.
The prevalence of IIH in the USA is about 1 per 100,000, and it mainly affects adult women in their 20s and 30s [4, 5] . Among morbidly obese women, the frequency of IIH is reported to be as high as 19.3 per 100,000. Regional differences in the frequency of IIH have been reported; the frequency of IIH in Africa is 2.2 per 100,000, while in Japan it is only 0.03 per 100,000. More than 60% of children with IIH are older than 10 years. Additionally, there is an identifiable cause of the intracranial hypertension in 84% of children younger than 6 years [1, 2, 6] . Thus, most cases of intracranial hypertension are not idiopathic in young chil-dren, and it is generally accepted that the incidence of true prepubertal IIH is much rarer than adult IIH.
It has recently been reported that the clinical features of childhood IIH, in particular prepubertal IIH, differ from those of adult IIH [1, 2] . The differences are the absence of differences in the sex distribution at the onset and the absence of a significant correlation with obesity. In addition, adult IIH patients often complain of headaches, have transient low vision, and tinnitus, while pediatric IIH patients often complain of restlessness, dizziness, and neck pain. However, adolescent IIH patients have clinical features similar to that of adult IIH. Currently, there is ongoing prospective study of the treatment of IIH in adults, but no data exist in children [1] . Most children respond to typical medical treatment such as intravenous carbonic anhydrase or steroids. Indication for surgical treatment include initial severe visual dysfunction or a worsening of the results of a visual test [6] . At the moment, because the etiology of IIH in children remains unclear, a specific treatment has not yet developed [1] .
Cerebral venous sinus thrombosis (CVST) can be a cause of intracerebral hypertension. Although there are overlapping symptoms in CVST and IIH, the treatments are different. Thus, CVST must be ruled out in the diagnosis of IIH, but it is not possible to diagnose CVST based solely on head CT and MRI examinations. It is essential to perform MR venography in all patients with intracranial hypertension to make a diagnosis of CVST. The incidence of CVST is 9.4% in patients with IIH [7] . Other causes for intracerebral hypertension such as acute toxic encephalopathy and arachnoiditis are usually ruled out by MRI examination and medical history.
Our patient was not obese and was prepubertal. He did not have a history of head injury, medication use, or otitis media, and MRI and MRV ruled out cranial sinus thrombosis and other possible causes. These findings suggested that the patient had true IIH.
Several reports have discussed the prognosis for the visual function in pediatric patients with IIH. While some studies reported that visual impairments were extremely rare in these children, and when present, they were not severe or permanent. However, others found that 13-60% had some degree of visual impairment, and 9% had severe persistent impairments [1, 6, 8] . One study compared the visual impairments in IIH patients at different ages and reported that the prognosis for good visual function was worse in adolescent patients than in prepubertal patients [9] . Most studies found that pediatric IIH patients responded to therapy better than adult patients [8] . However, a surgical procedure was necessary in our case. Since visual impairment is the only severe complication for both children and adults, ophthalmologists can play an important role during the follow-up of this disease. It has been suggested that there is a correlation between poor visual prognosis and the presence of severe papilledema at the initial visit [10] . Surgery is necessary when the visual impairment is severe or intracranial pressure is unresponsive to conservative therapy [1, 10, 11] .
Our patient had severely reduced vision in both eyes at the initial visit, and because the vision did not improve after medical therapy, a VP shunt was created. Although the papilledema improved over time, the patient had residual optic nerve atrophy, and the visual acuity did not recover. In one report on children younger than 11 years of age, it was found that the visual function did not change markedly after therapy [12] , while in another report, it was reported that the visual acuity transiently decreased to less than hand motion due to optic nerve atrophy, but finally improved to 20/20 [6] . This report indicates that our patient should be carefully monitored in the future.
In conclusion, we report our findings in a case of severe pediatric IIH which is very rare in the Japanese population. While many studies have found that the prognosis is generally good in pediatric IIH patients [1, 6, 11] , a collaboration among pediatricians, neurosurgeons, and ophthalmologists is essential for early diagnosis and treatment of IIH. The role of an ophthalmologist is necessary for early detection, and the therapeutic planning to prevent vision reduction which is the only severe complication of IIH.
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